JP2018538292A5 - - Google Patents

Download PDF

Info

Publication number
JP2018538292A5
JP2018538292A5 JP2018529981A JP2018529981A JP2018538292A5 JP 2018538292 A5 JP2018538292 A5 JP 2018538292A5 JP 2018529981 A JP2018529981 A JP 2018529981A JP 2018529981 A JP2018529981 A JP 2018529981A JP 2018538292 A5 JP2018538292 A5 JP 2018538292A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
cancer
solvate
moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018529981A
Other languages
English (en)
Japanese (ja)
Other versions
JP6867652B2 (ja
JP2018538292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/080453 external-priority patent/WO2017097986A1/en
Publication of JP2018538292A publication Critical patent/JP2018538292A/ja
Publication of JP2018538292A5 publication Critical patent/JP2018538292A5/ja
Application granted granted Critical
Publication of JP6867652B2 publication Critical patent/JP6867652B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018529981A 2015-12-09 2016-12-09 癌療法のためのモノマレイミド官能化白金化合物 Expired - Fee Related JP6867652B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15198739.3 2015-12-09
EP15198739 2015-12-09
PCT/EP2016/080453 WO2017097986A1 (en) 2015-12-09 2016-12-09 Monomaleimide-functionalized platinum compounds for cancer therapy

Publications (3)

Publication Number Publication Date
JP2018538292A JP2018538292A (ja) 2018-12-27
JP2018538292A5 true JP2018538292A5 (https=) 2020-01-23
JP6867652B2 JP6867652B2 (ja) 2021-05-12

Family

ID=54849106

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018529981A Expired - Fee Related JP6867652B2 (ja) 2015-12-09 2016-12-09 癌療法のためのモノマレイミド官能化白金化合物

Country Status (21)

Country Link
US (2) US10723748B2 (https=)
EP (1) EP3386997B1 (https=)
JP (1) JP6867652B2 (https=)
CN (1) CN108368143B (https=)
AU (1) AU2016367306B2 (https=)
CA (1) CA3004630A1 (https=)
CY (1) CY1124529T1 (https=)
DK (1) DK3386997T3 (https=)
ES (1) ES2898704T3 (https=)
HR (1) HRP20211466T1 (https=)
HU (1) HUE056897T2 (https=)
IL (1) IL259864B (https=)
LT (1) LT3386997T (https=)
MX (1) MX377528B (https=)
PL (1) PL3386997T3 (https=)
PT (1) PT3386997T (https=)
RS (1) RS62412B1 (https=)
SG (1) SG11201804885TA (https=)
SI (1) SI3386997T1 (https=)
SM (1) SMT202100709T1 (https=)
WO (1) WO2017097986A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3797768A1 (en) * 2014-06-23 2021-03-31 Placon Therapeutics, Inc. Maleimide-functionalised platinum for use in the treatment of cancer
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN109171001A (zh) * 2018-09-14 2019-01-11 上海烟草集团有限责任公司 草酸钠在降低卷烟烟气中TSNAs释放量中的应用
IL294392A (en) * 2019-12-31 2022-08-01 Kinnate Biopharma Inc Treatment of cancer with cdk12/13 inhibitors
US20230339997A1 (en) * 2020-09-11 2023-10-26 Shanghai Haiju Biological Technology Co., Ltd. Class of platinum compounds for treating cancer, and method for preparation thereof
CN114163479B (zh) * 2020-09-11 2025-05-16 上海海聚生物科技有限公司 一类治疗癌症用的铂类化合物及其制备方法
CN114539320B (zh) * 2020-11-25 2026-01-27 北京大学 辐射激活的四价铂配合物及其用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CH605550A5 (https=) 1972-06-08 1978-09-29 Research Corp
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
DE3169595D1 (en) 1980-11-10 1985-05-02 Gersonde Klaus Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
DE3374837D1 (en) 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
DE3218121A1 (de) 1982-05-14 1983-11-17 Leskovar, Peter, Dr.-Ing., 8000 München Arzneimittel zur tumorbehandlung
EP0102324A3 (de) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipide und Tenside in wässriger Phase
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
JPS607934A (ja) 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソ−ムの製造方法
HUT35524A (en) 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
DE3483949D1 (de) 1983-09-26 1991-02-21 Udo Dr Med Ehrenfeld Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
DE3474511D1 (en) 1983-11-01 1988-11-17 Terumo Corp Pharmaceutical composition containing urokinase
CS269719B1 (en) 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
DE19636889A1 (de) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
AU756693B2 (en) 1997-09-29 2003-01-23 Novartis Ag Stabilized bioactive preparations and methods of use
US7112324B1 (en) 1998-04-21 2006-09-26 Micromet Ag CD 19×CD3 specific polypeptides and uses thereof
DE19926154A1 (de) 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
DE10314780A1 (de) 2003-03-19 2004-09-30 Ktb Tumorforschungsgesellschaft Mbh Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
UA80872C2 (uk) 2003-03-31 2007-11-12 Пліва-Лахема А.С. Фармацевтична композиція, що містить як активну речовину платиновий комплекс, і спосіб її виготовлення
CZ296169B6 (cs) 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
US20060205810A1 (en) 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations
CZ300120B6 (cs) 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300590B6 (cs) 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300424B6 (cs) 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
RU2014124984A (ru) 2011-12-05 2016-01-27 Идженика Биотерапьютикс, Инк. Конъюгаты антитело-лекарственное средство и родственные соединения, композиции и способы
JP6355563B2 (ja) * 2012-02-27 2018-07-11 アムニクス オペレーティング インコーポレイテッド Xten共役組成物およびそれを製造する方法
WO2015052516A1 (en) * 2013-10-08 2015-04-16 Atlas Genetics Limited Labelling compounds and their use in assays
EP3089745A4 (en) 2013-12-31 2017-05-17 Placon Therapeutics, Inc. Compounds, compositions, and methods for the treatment of cancers
EP3797768A1 (en) * 2014-06-23 2021-03-31 Placon Therapeutics, Inc. Maleimide-functionalised platinum for use in the treatment of cancer
EP3313392B1 (en) 2015-06-23 2020-09-16 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
US20180186823A1 (en) 2015-06-23 2018-07-05 Placon Therapeutics, Inc. Platinum compounds, compositions, and uses thereof
EP3313527B1 (en) 2015-06-29 2021-02-24 Case Western Reserve University Anticancer drug-containing plant virus particles
NZ739830A (en) 2015-07-12 2021-12-24 Hangzhou Dac Biotech Co Ltd Bridge linkers for conjugation of cell-binding molecules
WO2017214024A1 (en) 2016-06-06 2017-12-14 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
JP2019524706A (ja) 2016-07-08 2019-09-05 ジェネンテック, インコーポレイテッド Muc16陽性癌治療の応答性を評価するためのヒト精巣上体タンパク質4(he4)の使用
WO2018026742A1 (en) 2016-08-01 2018-02-08 Askgene Pharma Inc. Novel antibody-albumin-drug conjugates (aadc) and methods for using them
CN108164512B (zh) 2017-12-27 2021-05-25 沈阳药科大学 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用
CN108187063B (zh) 2018-01-09 2020-09-08 沈阳药科大学 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药

Similar Documents

Publication Publication Date Title
JP2018538292A5 (https=)
JP2018138577A5 (https=)
JP2012505916A5 (https=)
JP2020525429A5 (https=)
JP2020533277A5 (https=)
JP2013522292A5 (https=)
JP2020518669A5 (https=)
JP2017530171A5 (https=)
JP2018511590A5 (https=)
RU2019121922A (ru) Композиции и способы лечения рака
NZ603654A (en) Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
JP2019535744A5 (https=)
JP2019512478A5 (https=)
JP2019511483A5 (https=)
JP2019508496A5 (https=)
JP2023510737A5 (https=)
JP2017538677A5 (https=)
JP2016153410A5 (https=)
JP2017526662A5 (https=)
HRP20211466T1 (hr) Spojevi platine funkcionalizirani monomaleimidom, namijenjeni terapiji raka
JP2013520502A5 (https=)
JP2016503414A5 (https=)
JP2010540556A5 (https=)
JP2022071077A5 (https=)
JP2014524476A5 (https=)